Genelux Corporation SEC filings GNLX
Genelux Corporation has 359 filings in SEC EDGAR's recent list, going back to May 5, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 22, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| 424B5 | Prospectus supplement | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| 8-K |
Current report
Material agreement
|
Mar 19, 2026 | Mar 19, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Dec 30, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 3, 2025 | Aug 27, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Jul 11, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jul 11, 2025 | — |
| DEF 14A | Proxy statement | Jul 11, 2025 | Jul 11, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| FWP | Free writing prospectus | Mar 25, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2025 | Jan 29, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2024 | Sep 23, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 6, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 1, 2024 | Aug 1, 2024 |
| ARS | Annual report to shareholders | Jun 14, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jun 14, 2024 | — |
| DEF 14A | Proxy statement | Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 5, 2024 | Jun 3, 2024 |
| 424B5 | Prospectus supplement | May 24, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
May 24, 2024 | May 23, 2024 |
| 424B5 | Prospectus supplement | May 23, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 9, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2024 | Apr 1, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 8, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 2, 2024 | Feb 2, 2024 |
| S-3 | Shelf registration | Feb 2, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 24, 2023 | Nov 21, 2023 |
| S-8 | Employee stock plan registration | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 14, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2023 | Aug 28, 2023 |
| DEFA14A | Additional proxy material | Aug 24, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| ARS | Annual report to shareholders | Jul 20, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Jul 20, 2023 | — |
| DEF 14A | Proxy statement | Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 19, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jul 14, 2023 | Jul 10, 2023 |
| EFFECT | Filing | Jul 3, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| D | Filing | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2023 | — |
| S-1 | Registration statement | Jun 28, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| D | Filing | Jun 15, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 12, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2023 | May 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| SEC STAFF LETTER | Filing | Jan 26, 2023 | — |
| S-8 | Employee stock plan registration | Jan 26, 2023 | — |
| 424B4 | Prospectus | Jan 26, 2023 | — |
| CERT | Filing | Jan 26, 2023 | — |
| EFFECT | Filing | Jan 25, 2023 | — |
| 8-A12B | Filing | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| FWP | Free writing prospectus | Jan 13, 2023 | — |
| S-1/A | Amended registration statement | Jan 10, 2023 | — |
| S-1/A | Amended registration statement | Dec 23, 2022 | — |
| FWP | Free writing prospectus | Nov 4, 2022 | — |
| CORRESP | Letter to the SEC | Nov 4, 2022 | — |
| S-1/A | Amended registration statement | Nov 4, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| S-1/A | Amended registration statement | Oct 13, 2022 | — |
| FWP | Free writing prospectus | Oct 4, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| S-1/A | Amended registration statement | Sep 19, 2022 | — |
| SEC STAFF LETTER | Filing | Sep 8, 2022 | — |
| CORRESP | Letter to the SEC | Aug 29, 2022 | — |
| S-1/A | Amended registration statement | Aug 29, 2022 | — |
| CORRESP | Letter to the SEC | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jun 24, 2022 | — |
| S-1 | Registration statement | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2022 | — |
| DRSLTR | Filing | May 20, 2022 | — |
| DRS/A | Filing | May 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2021 | — |
| DRSLTR | Filing | Jun 24, 2021 | — |
| DRS/A | Filing | Jun 24, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2021 | — |
| DRS | Filing | May 7, 2021 | — |
| D | Filing | Jun 6, 2012 | — |
| D | Filing | Jul 9, 2010 | — |
| D | Filing | Apr 9, 2009 | — |
| REGDEX | Auto-generated paper document | Nov 12, 2008 | — |
| REGDEX | Auto-generated paper document | Nov 8, 2007 | — |
| REGDEX | Auto-generated paper document | Dec 1, 2006 | — |
| REGDEX | Auto-generated paper document | Nov 1, 2005 | — |
| REGDEX/A | Auto-generated paper document | Nov 22, 2004 | — |
| REGDEX | Auto-generated paper document | Jul 23, 2004 | — |
| REGDEX | Auto-generated paper document | May 5, 2003 | — |
Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNLX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1231457
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.